One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in <i>CYP2C19</i> Loss-of-Function Carriers With Stroke or TIA Trial-Reference-Cited by-同舟云学术

One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA Trial

Published:2024-02-13 Issue:3 Volume:102 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Meng Xia¹,Wang Anxin¹,Tian Xue¹,Johnston Claiborne¹,Li Hao¹,Bath Philip M.¹^ORCID,Xu Qin¹,Zhang Yijun¹,Xie Xuewei¹,Jing Jing¹,Lin Jinxi¹,Wang Yilong¹,Zhao Xingquan¹,Li Zixiao¹^ORCID,Jiang Yong¹^ORCID,Liu Liping¹^ORCID,Wang Yongjun¹

Affiliation:

1. From the Department of Neurology (X.M., A.W., X.T., H.L., Y.Z., X.X., J.J., J.L., Yi.W., X.Z., Z.L., L.L., Y.J., Yo.W.) and Advanced Innovation Center for Human Brain Protection (Yo.W.), Beijing Tiantan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (X.M., A.W., X.T., H.L., Y.Z., X.X., J.J., J.L., Yi.W., X.Z., Z.L., L.L., Y.J., Yo.W.), Beijing; Department of Epidemiology and Health Statistics (X.T., Y.Z.), School of Public Health, Capital...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207809

Reference18 articles.

1. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

2. A 5-Decade Analysis of Incidence Trends of Ischemic Stroke After Transient Ischemic Attack

3. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack

4. Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial

5. Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA